DK0720483T3 - Anvendelse af væksthormon ved fremstilling af et medikament til behandling af iskæmisk hjerneödelæggelse og demens - Google Patents

Anvendelse af væksthormon ved fremstilling af et medikament til behandling af iskæmisk hjerneödelæggelse og demens

Info

Publication number: DK0720483T3
Authority: DK; Denmark
Prior art keywords: treatment; growth hormone; dementia; medicament; manufacture
Prior art date: 1993-09-21

Application number

DK94928538T

Other languages

English (en)

Inventor

Bengt Bengtsson

Olle G P Isaksson

Jan Johansson

Original Assignee

Sahltech Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-09-21

Filing date

1994-09-21

Publication date

2004-08-09

1994-09-21 Application filed by Sahltech Ab filed Critical Sahltech Ab

2004-08-09 Application granted granted Critical

2004-08-09 Publication of DK0720483T3 publication Critical patent/DK0720483T3/da

Links

102000018997 Growth Hormone Human genes 0.000 title abstract 3
108010051696 Growth Hormone Proteins 0.000 title abstract 3
239000000122 growth hormone Substances 0.000 title abstract 3
206010012289 Dementia Diseases 0.000 title 1
230000006931 brain damage Effects 0.000 title 1
231100000874 brain damage Toxicity 0.000 title 1
208000029028 brain injury Diseases 0.000 title 1
239000003814 drug Substances 0.000 title 1
230000000302 ischemic effect Effects 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
108090000723 Insulin-Like Growth Factor I Proteins 0.000 abstract 2
102000004218 Insulin-Like Growth Factor I Human genes 0.000 abstract 1
102000004374 Insulin-like growth factor binding protein 3 Human genes 0.000 abstract 1
108090000965 Insulin-like growth factor binding protein 3 Proteins 0.000 abstract 1
102000013275 Somatomedins Human genes 0.000 abstract 1
210000001175 cerebrospinal fluid Anatomy 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Endocrinology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychiatry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

DK94928538T 1993-09-21 1994-09-21 Anvendelse af væksthormon ved fremstilling af et medikament til behandling af iskæmisk hjerneödelæggelse og demens DK0720483T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9303068A SE9303068D0 (sv)	1993-09-21	1993-09-21	New use
PCT/SE1994/000875 WO1995008345A1 (en)	1993-09-21	1994-09-21	Use of growth hormone for increasement of concentration of gh, igf-i and igfbp-3 in cerebrospinal fluid

Publications (1)

Publication Number	Publication Date
DK0720483T3 true DK0720483T3 (da)	2004-08-09

Family

ID=20391162

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK94928538T DK0720483T3 (da)	1993-09-21	1994-09-21	Anvendelse af væksthormon ved fremstilling af et medikament til behandling af iskæmisk hjerneödelæggelse og demens

Country Status (13)

Country	Link
US (1)	US5736515A (da)
EP (1)	EP0720483B1 (da)
JP (1)	JPH09502973A (da)
AT (1)	ATE263573T1 (da)
AU (1)	AU683306B2 (da)
CA (1)	CA2168570C (da)
DE (1)	DE69433687T2 (da)
DK (1)	DK0720483T3 (da)
ES (1)	ES2218529T3 (da)
NZ (1)	NZ274025A (da)
PT (1)	PT720483E (da)
SE (1)	SE9303068D0 (da)
WO (1)	WO1995008345A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6025368A (en) *	1997-02-25	2000-02-15	Celtrix Pharmaceuticals, Inc.	Method for treating the symptoms of chronic stress-related disorders using IGF
US6015786A (en) *	1997-02-25	2000-01-18	Celtrix Pharmaceuticals, Inc.	Method for increasing sex steroid levels using IGF or IGF/IGFBP-3
US6514937B1 (en)	1997-02-25	2003-02-04	Celtrix Pharmaceuticals, Inc.	Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3
US7304029B1 (en)	1998-09-03	2007-12-04	Neuren Pharmaceuticals Ltd.	Neuroprotective effect of growth hormone
EP1149583A3 (en) *	2000-04-13	2001-11-14	Pfizer Products Inc.	Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues
MXPA06000954A (es) *	2003-07-29	2006-05-04	Ares Trading Sa	Uso de hormona del crecimiento humano en atrofia de multiples sistemas.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2974088A (en) *	1958-07-18	1961-03-07	Merck & Co Inc	Method of preparing growth hormone
US3118815A (en) *	1959-09-28	1964-01-21	Upjohn Co	Growth hormone and recovery thereof
EP0103395A3 (en) *	1982-08-17	1985-05-22	Biogen N.V.	Dna sequences, recombinant dna molecules and processes for producing bovine growth hormone-like polypeptides in high yield
US4521409A (en) *	1983-10-03	1985-06-04	Cornell Research Foundation, Inc.	Use of growth hormone to enhance ruminant mammary development
WO1986004308A1 (en) *	1985-01-28	1986-07-31	Seung Moon Park	Lighting apparatus for wheels of vehicles
US4670249A (en) *	1985-04-12	1987-06-02	International Minerals & Chemical Corp.	Growth-promoting compositions
US4786501A (en) *	1985-07-15	1988-11-22	International Minerals & Chemical Corp.	Cylindrical implants for the controlled release of growth hormones
IL79681A (en) *	1985-08-12	1991-06-10	Int Minerals & Chem Corp	Transition metal complexes of growth hormones and their prolonged release compositions
ZA866218B (en) *	1985-08-23	1988-03-30	Lilly Co Eli	Injectable sustained release formulation
US4977140A (en) *	1985-08-23	1990-12-11	Eli Lilly And Company	Injectable sustained release formulation
US4857506A (en) *	1987-01-12	1989-08-15	American Cyanamid Company	Sustained release growth hormone compositions for parenteral administration and their use
US4863736A (en) *	1987-03-16	1989-09-05	Monsanto Company	Somatotropin prolonged release
NZ223842A (en) *	1988-03-10	1991-07-26	Amgen Inc	Porcine growth hormone analogues, production using genetic engineering and compositions for promoting growth in mammals

1993
- 1993-09-21 SE SE9303068A patent/SE9303068D0/xx unknown
1994
- 1994-09-21 JP JP7509721A patent/JPH09502973A/ja active Pending
- 1994-09-21 WO PCT/SE1994/000875 patent/WO1995008345A1/en not_active Ceased
- 1994-09-21 PT PT94928538T patent/PT720483E/pt unknown
- 1994-09-21 US US08/602,728 patent/US5736515A/en not_active Expired - Lifetime
- 1994-09-21 AU AU77933/94A patent/AU683306B2/en not_active Ceased
- 1994-09-21 DK DK94928538T patent/DK0720483T3/da active
- 1994-09-21 ES ES94928538T patent/ES2218529T3/es not_active Expired - Lifetime
- 1994-09-21 EP EP94928538A patent/EP0720483B1/en not_active Expired - Lifetime
- 1994-09-21 NZ NZ274025A patent/NZ274025A/en not_active IP Right Cessation
- 1994-09-21 CA CA002168570A patent/CA2168570C/en not_active Expired - Fee Related
- 1994-09-21 AT AT94928538T patent/ATE263573T1/de active
- 1994-09-21 DE DE69433687T patent/DE69433687T2/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2168570C (en)	2009-04-07
ATE263573T1 (de)	2004-04-15
ES2218529T3 (es)	2004-11-16
SE9303068D0 (sv)	1993-09-21
PT720483E (pt)	2004-08-31
US5736515A (en)	1998-04-07
NZ274025A (en)	2005-03-24
DE69433687D1 (de)	2004-05-13
WO1995008345A1 (en)	1995-03-30
DE69433687T2 (de)	2005-03-17
CA2168570A1 (en)	1995-03-30
AU683306B2 (en)	1997-11-06
EP0720483B1 (en)	2004-04-07
EP0720483A1 (en)	1996-07-10
JPH09502973A (ja)	1997-03-25
AU7793394A (en)	1995-04-10

Similar Documents

Publication	Publication Date	Title
DK0659083T3 (da)	2000-06-13	Forebyggelse og behandling af perifer neuropati
DK0706378T3 (da)	2003-05-05	Ny farmaceutisk formulering.
RU94046291A (ru)	1996-11-10	Способ профилактики и лечения периферической невропатии, композиция, содержащая инсулин-подобный фактор роста i
SE9604793L (sv)	1998-06-21	Nya Kristallmodifikationer
ATE185548T1 (de)	1999-10-15	Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
DK1011632T3 (da)	2004-03-29	Farmaceutisk præparat til behandling af dysmenoré og præmature fødselsveer
EP0666753A4 (en)	1995-01-26	METHOD FOR TREATING COMPLICATIONS AND PATHOLOGY AT DIABETES.
ATE29729T1 (de)	1987-10-15	Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus.
DE69230112D1 (de)	1999-11-11	Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
PT99513A (pt)	1992-09-30	Processo para a preparacao de composicoes farmaceuticas contendo profarmacos de morfina para administracao topica por via transdermica
DE69616333D1 (de)	2001-11-29	Thip zur behandlung von schlafstörungen
DK0436469T3 (da)	1995-04-03	Præparat og fremgangsmåde til behandling af osteoporose i pattedyr
PL320167A1 (en)	1997-09-15	2,2-dichloroalkanocarboxylic acids, method of obtaining them and therapeutic agents containing such compounds and their application in treating insulin immunity
DE69316013D1 (de)	1998-02-05	Verwendung von phosphinate zur behandlung der osteoporose
DK0630365T3 (da)	1998-03-02	Fremgangsmåde til fremstilling af beta-phenylisoserin og analoge deraf
DK0561846T3 (da)	1995-08-21	4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning
SE9303068D0 (sv)	1993-09-21	New use
DE69301750D1 (de)	1996-04-18	Verwendung von 1-Alpha,24(R)-Dihydroxy-22(E)-Dehydrovitamin-D3 zur Herstellung eines Arzneimittels zur Behandlung der Osteoporose
DK0586589T3 (da)	1997-09-22	Amylin- eller amylinanalogpræparat, som eventuelt indeholder insulin, til behandling af anoreksi og beslægtede tilstande
DE69332541D1 (de)	2003-01-16	Il-6 enthaltende pharmazeutische zusammensetzungen ihre verfahren zur behandlungder verbrauchenden hämorrhagischen thrombozythämie
DE69023006D1 (de)	1995-11-16	Verfahren zur behandlung von thrombocytopenie und dafür geeignete pharmazeutische zusammensetzungen.
DE69207698D1 (de)	1996-02-29	Arylalkylester der 4,5-dihydoxy-9,10-dihydro-9,10-dioxo-2-anthracencarbonsäure und deren therapeutische verwendung
DE69026087D1 (de)	1996-04-25	Substituierte 2-imidazoline und verfahren zur herstellung sowie deren verwendung
NO911237L (no)	1991-10-01	Fremgangsmaate for fremstilling av hydroxymethyl-indolizidiner og kinolizidiner
DE69627379D1 (de)	2003-05-15	Igf-i and -ii zur behandlung von krankheiten im zentralnervensystem